Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2011; 17(48): 5260-5266
Published online Dec 28, 2011. doi: 10.3748/wjg.v17.i48.5260
Published online Dec 28, 2011. doi: 10.3748/wjg.v17.i48.5260
Figure 1 Synthesis of α-Gal epitopes on tumor cell membranes.
A: Negative control, tumor cells treated with neuraminidase only, cells with no synthesized epitopes; B: Tumor cells treated with both neuraminidase and α1,3GT, > 60% tumor cells with synthesized α-Gal epitopes.
Figure 2 Kaplan Meier survival curves of the patients with stage III hepatocellular carcinoma.
Study group, n = 9; control group, n = 9; P = 0.00121.
- Citation: Qiu Y, Xu MB, Yun MM, Wang YZ, Zhang RM, Meng XK, Ou-Yang XH, Yun S. Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells. World J Gastroenterol 2011; 17(48): 5260-5266
- URL: https://www.wjgnet.com/1007-9327/full/v17/i48/5260.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i48.5260